Viracta Therapeutics, Inc.
VIRX · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $22 | $55 | $116 | $259 |
| - Cash | $12 | $37 | $104 | $47 |
| + Debt | $26 | $25 | $5 | $6 |
| Enterprise Value | $35 | $44 | $18 | $218 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | -100% | – |
| Gross Profit | -$0 | -$0 | -$0 | $0 |
| % Margin | – | – | – | 73.3% |
| EBITDA | -$47 | -$48 | -$114 | -$19 |
| % Margin | – | – | – | -15,640.8% |
| Net Income | -$51 | -$50 | -$203 | -$19 |
| % Margin | – | – | – | -15,999.2% |
| EPS Diluted | -1.32 | -1.32 | -6.37 | -0.52 |
| % Growth | 0% | 79.3% | -1,125% | – |
| Operating Cash Flow | -$40 | -$35 | -$19 | -$16 |
| Capital Expenditures | -$0 | -$0 | -$4 | -$0 |
| Free Cash Flow | -$40 | -$36 | -$23 | -$16 |